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ABSTRACT
Size-exclusion chromatography (SEC) is a method of choice for the analysis of protein aggregates in pharma​ceuticals. The United States and European Pharmacopoeias currently use a SEC method with an acidic pH mobile phase to assess the content of aggregates in insulin formulations.
In this article, we analyzed aggregated human insulin samples and demonstrated that both methods under neutral conditions, namely neutral pH SEC (nSEC) and capillary gel electrophoresis (CGE), yield to similar aggregate content contrary to SEC under acidic conditions (aSEC). aSEC showed polymeric complexes that were not observed in nSEC and CGE. During method development, the effect on SEC profiles of arginine and acet​onitrile were highlighted. In CGE, the effect of SDS on disruption of non-covalent insulin aggregates was con​firmed and the benefit of sodium deoxycholate addition in sieving gel was discussed. The three methods were applied to the analysis of an insulin formulation and similar results to those obtained for human insulin as raw material were observed. Finally, the CGE method was used to study the stability of human insulin under different storage conditions.





Insulin is a biopharmaceutical composed of 51 amino acids widely used as a model to study amyloid fibrillation. It is well demonstrated that this protein is prone to aggregate and forms fibrils when submitted to denaturing factors such as temperature, ionic strength and pH [1,2].
Fibril formation is most often described as a process that includes three successive stages, namely nucleation, fibrillation or elongation and equilibration [3]. Insulin aggregation may be responsible for complications during treatment by depositions of fibrils in sub​cutaneous tissues giving rise to unwanted immune responses [4]. For that reason, strict limitations of the aggregate content in final drug products are defined.
Many techniques are described in literature to analyze protein ag​gregates. Nevertheless, both United States and European Pharmacopoeias use size-exclusion chromatography (SEC) to assess the level of high molecular weight species and dimers in human insulin raw materials and in insulin formulations [5]. The SEC protocol is based on the results of a collaborative study involving manufacturers and na​tional control laboratories from Europe, Japan and United States that pointed out in 1996 the interest of an acidic pH mobile phase composed of glacial acetic add, acetonitrile and arginine to separate the different species [6].
The good method reproducibility and its ease of use make SEC the technique of choice for the analysis of protein aggregates in bio​pharmaceuticals [7]. But one of the main drawbacks of this technique is the possible change in aggregate composition and content during the analysis that can be observed particularly when the mobile phase composition is very different from the sample dissolution medium [8]. As an example, most insulin products are formulated in a pH 7.4 buffer but are analyzed under acidic conditions.
Tantipolphan et al. applied SEC under neutral conditions (nSEC) for the analysis of insulin aggregates [9]. They showed that the elution behavior of insulin strongly depends on the pH of the mobile phase as well as on the presence of zinc and arginine. They concluded that the chromatographic behavior of insulin is almost not influenced by the association state of insulin in formulations. Favero-Retto et al. [10] tried to assess the presence of high molecular weight insulin products in SEC using a mobile phase made up of 0.02 M Tris HCl and 0.1 M NaCl at pH 7.4 but they were not able to detect any insulin oligomers.
Beside SEC, capillary electrophoresis (CE) has also been used to analyze the aggregation process of amyloid peptides and proteins. Sabella et al. [11] used CE to follow the steps of β-amyloid (Ab) nu​cleation. Picou et al. [12] also studied β-amyloid peptides in CE to differentiate monomeric and aggregated forms. Brinet et al. [13] de​veloped a CE method to analyze small Aβ 1-42 oligomeric species and used it to evaluate the antioligomerization activity of molecules.
Dimerization and hexamerization of insulin was studied with the use of CE and electrophoretic mobilities calculations. However, no se​paration of monomeric and aggregated forms was displayed [14,15]. 
Pryor et al were the first to show the separation of several populations of oligomers at different incubation times in capillary zone electro​phoresis (CZE) using a pH 8.0 background electrolyte (BGE) and phy​siological salt concentration [1].
The capillary gel electrophoresis (CGE) mode employs a sieving gel as separation medium. Large molecules tend to migrate slower in the viscous sieving matrix than the small ones. CGE is often used for DNA analysis, where molecules may vary greatly in length but have a quite constant charge [16]. CGE has also been used for the analysis of pro​teins in biological fluids, food products, agricultural products as well as in clinical and pharmaceutical studies [17].
To enable proteins to migrate according to their size in sieving gel, sodium dodecyl sulfate-CGE (SDS-CGE) is often used. Briefly, SDS is added to the matrix to mask the native charges of proteins giving them a uniform charge/size ratio and thus allowing the separation of proteins according to their size [17]. Nevertheless, since SDS is a detergent it can denature proteins and disrupt non-covalently aggregates before detec​tion [18].
In this work, insulin aggregation was investigated in SEC under acidic conditions (aSEC) according to a slightly modified version of the European Pharmacopoeia method as well as in SEC using a pH 7.4 mobile phase (nSEC). Moreover, a CGE method without SDS was for the first time used to separate insulin monomers and dimers. These results were compared to those obtained in SEC.
2. Materials and methods
2.1. Chemicals and reagents
Boric acid, ethylenediamine tetra-acetic acid (EDTA), glacial acetic acid, sodium hydroxide (NaOH) were purchased from VWR chemicals (Leuven, Belgium). Monosodium dihydrogen orthophosphate (NaH2PO4), disodium monohydrogen orthophosphate (Na2HPO4), gly​cerol, hydrochloric acid (HCl) (37% wt.) and tris(hydroxymethyl)ami- nomethane (Tris) were obtained from Merck (Darmstadt, Germany). Angiotensin 1, L-arginine, human insulin, α-lactalbumin, β-lactoglo- bulin A, polyethylene oxide (PEO), dextran from Leuconostoc me- senteroides (MW 1500,000-2800,000), sodium deoxycholate and pepsin were from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile (ACN) was purchased from JT Baker (Deventer, The Netherlands). Sodium dodecyl sulfate (SDS) was provided by Fisher scientific (Loughborough, United Kingdom). Ultrapure water was supplied by a Milli-Q equipment (Millipore, Bedford, MA, USA) and Chromafil syr​inge filters (0.20 μm) were from Macherey-Nagel (Duren, Germany). All chemicals were of analytical grade. Humuline® Regular (Eli​Lilly, Indianapolis, IN, USA) was purchased at a local pharmacy.


2.2. Size-exclusion chromatography (SEC)
SEC experiments were performed on an Agilent 1200 HPLC system (Agilent Technologies, Palo Alto, CA, USA) coupled to a diode-array detector (DE64260423). SEC-multi-angle light scattering (SEC-MALS) system consisted on a Shimadzu Prominence HPLC system (Shimadzu, Tokyo, Japan) equipped with a SP-20A diode-array detector, a RID-20A refractive index detector and a miniDAWN TREOS II (Wyatt Technology, Santa Barbara, Data analysis, CA, USA). Separation was performed using a Yarra™ 3 μm SEC-2000, LC Column (300 × 7.8 mm) protected with a SecurityGuard Standard Guard Cartridge System (Phenomenex, Torrance, CA, USA). This column was chosen for its surface inertness resulting in minimal stationary phase adsorption. The column compartment was thermostated at 20°C. UV absorbance de​tection was performed at 280 nm. The injection volume was 10 μL.
The acidic pH mobile phase (aSEC) was composed of glacial acetic acid R/acetonitrile R/arginine R (1.0g ∕ l); 9/20/65 (v ∕ v ∕ v). Compared to monograph conditions, acetic acid was reduced from 15 volumes to 9 volumes to be at pH 2.5 and preserve the integrity of Yarra™ column (pH 2.5 - pH 7.5). The neutral mobile phase was made up of 0.1 M sodium phosphate buffer (pH 7.4) instead of glacial acetic acid R and afterwards adjusted to pH 7.4 with glacial acetic acid. The following mobile phases were also prepared to study the influence of the mobile phase composition: (1) 0.1 M sodium phosphate buffer (pH 7.4), (2) 0.1 M sodium phosphate buffer (pH 7.4)∕arginine R (1.0 g ∕ l); 29/65 (v ∕ v) adjusted to pH 7.4 with acetic acid and (3) 0.1 M sodium phosphate buffer (pH 7.4) ∕ acetonitrile R; 74/20 (v ∕ v) adjusted to pH 7.4 with acetic acid (nSEC).
2.3. Capillary gel electrophoresis (CGE)
The experiments were conducted using a G7100 CE system (Agilent Technologies Waldbronn, Germany), equipped with a DAD detector. Electrophoretic separations were carried out in a 50 μm i.d. bare fused capillary (Agilent) with a total length of 33 cm and an effective length 8.5 cm and thermostated at 25°C. Samples were injected hydro​dynamically by applying a pressure of - 2 bar during 2 s and the se​paration was performed at + 30 kV with a 1.6 min ramping. UV de​tection was set at 220 nm. The coating procedure was adapted from Tran et al. [19]
Each new capillary was first conditioned by successive rinses of 5 min with H2O, 1 M NaOH, 0.1 M NaOH, and H2O. The capillary was coated by flushing with 1 M NaOH for 5 min, 1 M HCl for 10 min, H2O for 10 min, 0.2% PEO solution for 5 min and eventually with H2O for 5 min. The semi-permanent was regenerated at the beginning of each day by successive rinses with H2O (2 min at 2 bar), 0.1 M HCl (5 min at 2 bar), 0.2% PEO (5 min at 2 bar) and gel (10 min at 4 bar). Furthermore, coating was regenerated before each run by rinses at 4 bar with water (3 min), 0.1 M HCl (3 min), 0.2% PEO (5 min) and gel (10 min). At the end of each day, the capillary was washed with 0.1 M NaOH during 15 min, 0.1 M HCl during 5 min and H2O during 10 min.
The sieving gel composition, inspired from Ref. [20], was made up of 0.6 M Tris-borate buffer (pH 8.1), 0.005 M EDTA, 10% dextran (w,∕ v), 0.2% SDS (w ∕ v), 10% glycerol (v ∕ v). First, Tris-borate buffer con​taining EDTA and glycerol was prepared. Secondly, SDS was added and the mixture was submitted to agitation until complete dissolution. Eventually, dextran was slowly added to the preparation and stirred at room temperature for 18-24 h [20]. The two other gels discussed in this paper were prepared as previously described but without SDS or by addition of 0.2% sodium deoxycholate instead of SDS.
2.4. Sample preparation
2.4.1. Influence of the mobile phase composition in SEC
Human insulin was dissolved in 0.01 M HCl at a concentration of 4 mg∕ml.
2.4.2. Influence of the gel composition in CGE
Human insulin was dissolved in 0.01 M HCl at a concentration of 4 mg∕ml. Insulin aggregation was induced by heating at 37 0C and stirring at 1200 rpm with a thermomixer (Eppendorf, Germany) for 48 h.
2.4.3. Study of insulin aggregation by aSEC, nSEC and CGE
Human insulin was also dissolved in 0.01 M HCl at a concentration of 4 mg∕ml. Insulin aggregation was induced under the same conditions as in 2.4.2 and samples were collected before aggregation and after 8, 16, 24, 32, 40 and 48 h. They were kept in the fridge until incubation and analyzed just after incubation on the same day.
2.4.4. Application to the analysis of an insulin formulation
Humuline® Regular was analyzed under four different conditions. The samples were prepared as followed: no pretreatment, after addition of an acid (4 μL of 6 M HCl for 1 ml of Humuline), after agitation (24 h at 700 rpm at 37 °C) and after agitation of the acidified formulation (24 h at 700 rpm at 37 °C). All samples were analyzed on the same day.
2.4.5. Stability of human insulin at 4 °C, - 20 °C and at room temperature
A 16 mg/ml human insulin solution was prepared in 0.01 M HCl and then diluted to 4 mg/ml with the same solvent (insulin in acidic medium) or diluted to a concentration of 4 mg/ml with 0.1 M sodium phosphate buffer (pH 7.4) (insulin in neutral medium). Both samples were stored at room temperature (< 25 °C), in the fridge (4 °C) or in the freezer (-20 °C) and analyzed by CGE after 1, 5 and 15 days.


3. Results and discussion
3.1. Influence of the mobile phase composition in SEC
In this study, we first investigated the effect of additives on SEC profiles (Fig. 1). Indeed, the differences that may occur in SEC when changing parameters such as mobile phase composition, injection vo​lume and flow rate were highlighted in many studies [21]. A review from Arakawa et al. summarizes the effect of various mobile phase additives used in SEC on protein adsorption (in principle, there is no retention in SEC since there should not be any interaction with the stationary phase) but also on the protein sample itself [22]. For ex​ample, organic solvents such as acetonitrile are usually added to the mobile phase to reduce hydrophobic interactions and thus suppress adsorption. Nevertheless, they may also dissociate aggregates if the latter are linked through hydrophobic interactions or enhance protein aggregation caused by polar interactions. Moreover, organic solvents may precipitate proteins [22]. Amino acids such as arginine are sometimes also added to the mobile phase. Arginine is known to have anti-aggregation properties as it acts as protein refolding facilitation and solubilization agent [23]. But it is also used in the mobile phase to reduce nonspecific interactions of proteins with the stationary phase and thus to reduce the potential loss, improve peak shape and the quantitation of aggregates. [7,24,25].
In this study, we compared the SEC profile obtained under acidic pH mobile phase conditions adapted from the European Pharmacopoeia method (aSEC, Fig. 1A) [5] with those obtained using a neutral mobile phase (0.1 M phosphate buffer (pH 7.4), Fig. 1B). When human insulin was injected in aSEC conditions, the insulin monomer was detected as well as a species of higher molecular weight representing less than 0.1% of the insulin monomer peak area. Using a pH 7.4 phosphate buffer as mobile phase, a broad peak was observed at about 20 min and no species of higher molecular weight was detected. The bad peak shape was probably caused by strong protein interactions with the stationary phase [26] or by the presence of different association states during the elution [9].
To help prevent these interactions and improve peak shape, some additives were added to the neutral pH mobile phase. As shown in Figs. 1C and 1D, the addition of arginine or ACN in the mobile phase improved the peak shape but not the separation. On the contrary, the combination of arginine and ACN (Fig. 1E, nSEC) induced a reduction of the elution time as well as a significant improvement in the peak shape and in the separation of the species. The observed species re​presented 4% of the insulin monomer peak area. Watson et al. [26] studied the aggregation of proteins at neutral and acidic pH. They showed that no aggregate was detected at pH 6.9 while aggregates were detected when the pH was decreased below 5. Here, it is demonstrated that the addition of additives, when working at the same pH values, may enable the detection of aggregates.











Fig. 2. Influence of the sieving gel composition on the CGE profile. (A): 0.6 M tris-borate buffer pH 8.1/0.005 M EDTA/10% dextran (w∕v)∕0.2% SDS (w∕v)/ 10% glycerol (v∕v). (B): 0.6 M tris-borate buffer pH 8.1/0.005 M EDTA/10% dextran (w∕v)∕10% glycerol (v∕v). (C): 0.6 M tris-borate buffer pH 8.1/0.005 M EDTA/10% dextran (w∕v)∕0.2% sodium deoxycholate (w∕v)∕10% glycerol (v∕ v). A 4 mg human insulin solution in 0.01 M HCl, submitted to agitation for 48 h at 1200 rpm and 37 °C, was analyzed.

3.2. Influence of the gel composition in CGE
The next step of this study consisted in the optimization of a CGE method to analyze insulin aggregates. As shown in Fig. 2, three dif​ferent gel compositions were investigated (see Section 2.3 and legend to figures).
A semi-permanent neutral PEO coating was applied in order to prevent protein adsorption onto the capillary wall. PEO was flushed in the capillary between runs and bound to the wall through weak inter​actions inducing a neutral layer on the surface of the capillary. This coating was chosen for its ease of use, the low coating agent con​sumption and the possibility to completely regenerate the capillary between runs. Moreover, to reduce the analysis time, samples were injected at the short end of the capillary. The separation voltage was adjusted from + 16.5 kV initially to + 30 kV which reduced the ana​lysis time by a factor of two. The percentage of aggregates did not change when the voltage was increased, indicating that high voltage has no effect on non-covalent aggregate disruption.
SDS is frequently used in CGE sieving gels to mask protein intrinsic charge. As can be seen in Fig. 2A, when insulin was injected in CGE using a gel containing SDS, only one peak was detected. On the con​trary, when insulin was injected in a gel without SDS, two peaks could be observed (cf. Fig. 2B). This demonstrates that SDS disrupts non- covalent interactions between insulin monomers. Both species were also observed using a gel containing sodium deoxycholate (cf. Fig. 2C). Concentrations below and above the critical micelle concentration of sodium deoxycholate were tested (0.07%, 0.2%, 0.3% and 0.5%). No differences in the migration order of the compounds were observed. Even if both SDS and sodium deoxycholate are anionic surfactants, they do not have the same distribution of polar groups. SDS presents a charged headgroup (sulfate) and a hydrophobic chain. In addition to its carboxylic group, sodium deoxycholate has polar groups distributed in its hydrophobic moiety. [27] This difference in structure could explain the lower tendency of sodium deoxycholate to denaturate proteins.
As the lowest peak migrates first, it can be assumed that sodium deoxycholate does not bind to proteins like SDS and thus does not lead to a separation according to the molecular weight. Nevertheless, the analysis time was 2 min shorter and peak symmetry was improved compared to the results obtained with the gel without surfactant. Good intra-day precision for migration time (< 1.4%) was observed for both gels.
3.3. Study of insulin aggregation by aSEC, NSEC and CGE
Three of the conditions described above (aSEC, nSEC and CGE) were selected to study the aggregation of insulin and compare the results in term of aggregate content. Insulin was submitted to agitation under 1200 rpm at 37°C. Samples were collected before incubation (TO) and after 8, 16, 24, 32, 40 and 48 h of incubation.
In aSEC, beside the insulin monomer, two species were detected (Fig. 3A). The first species (*), which was observed at an elution time of 11.6 min, shows a small increase in the aggregate content as a function of the incubation time (from 0.28% at T0 to 0.39% after 48 h of in​cubation). Regarding the second species (**) with an elution time of 9.1 min, it significantly appeared after 32h of incubation (0.12%) and reached a maximum at 40 h (0.63%). The RSDs for that second species were 24% for T32, 13% for T40 and 18% for T48, respectively (see Table 1). These species correspond to dimers (*) and to polymeric in​sulin complexes (**) as described in the European Pharmacopoeia [5] as well as in the United States Pharmacopoeia.
In nSEC and CGE, only two peaks were detected (Fig. 3C-D). In nSEC, the percentage of the first species increased from 4.2% at T0 to 26% at T48. In CGE, it evolved from 0.64% at T0 to 24% at T48 (see Table 1). The RSDs calculated on 3 replicates were below 6% for each time of incubation (except for TO values for which RSDs were 14% and 11% for nSEC and CGE, respectively).
In nSEC as well as in aSEC, species with a higher molecular weight are excluded from the pores of the stationary phase and elute before smaller species [24]. SEC-MALS was used to assess the molecular weight of the detected species. The molecular weight of the second eluting specie was estimated at 5570 daltons which confirmed that this specie is a monomer and not a hexamer. The results concerning the first species were not interpretable. A calibration curve of four compounds (1 peptide (Angiotensin 1) and 3 proteins (α-lactalbumin, β-lactoglo- bulin A and pepsin)) was thus performed to assess the molecular weight of those species. The logarithm of the molecular weight was plotted in function of the retention time. A linear curve was obtained with esti​mated molecular weight for the second eluting species at 8184 daltons and at 9516 daltons for the first species. Differences observed between expected molecular weight (5808 and 11,616) and calculated ones could be explained by the presence of acetonitrile in the mobile phase and the small size of insulin. It could be assumed that the detected species was a dimer. Since this species was not detected in CGE when SDS was added to the gel (see Section 3.2), it could be defined as non- covalent dimer. Non-covalent interactions between insulin molecules have already been described in literature by Malik et al [28] to occur at the early stages of insulin aggregation induced by agitation.
In CGE with SDS, species migrate according to their size, with smaller species migrating first. When SDS is removed from the gel, species will migrate in the gel according to their charge/size ratio which can explain why non-covalent dimers migrate before monomers.
SEC and CGE are thus different techniques based on completely different separation principles. Moreover, the quantity of sample in​jected in SEC is substantially higher than in CGE and less abundant aggregates could thus be detected. In both separation techniques, a dilution effect of the compound into the running buffer may occur and could lead to the dissociation of the aggregates. Adsorption onto the stationary phase (in SEC) or onto the capillary wall (in CGE) may also alter the aggregate content in various ways [21].
The possible ways of sample modification during the separation are thus multiple. For this reason, the similar results arising from two fundamentally different techniques (nSEC and CGE) working at a pH close to that of the formulations, most probably reflect what is initially present in the sample and are not artifacts generated by these techni​ques. One of the major challenges when using separation techniques to assess the percentage of aggregates is to make sure that what is measured corresponds to what was initially present in the sample [21].





Fig. 3. Comparison of aSEC, nSEC and CGE profiles. Human insulin solutions (4 mg/ml in 0.01 M HCl) without pretreatment or submitted to agitation for 8, 16, 24, 32, 40 and 48 h at 1200 rpm and 37°C. (A) aSEC: glacial acetic acid R/acetonitrile R/arginine R (1.0 g ∕ l); 9/20/65 (v ∕ v ∕ v)). (B) Percentages of dimers and polymeric insulin complexes in aSEC as a function of the incubation time. The results are the means of three replicates. Error bars represent the standard deviations. (C) nSEC: 0.1 M sodium phosphate buffer (pH 7.4)∕acetonitrile R/arginine R (1.0 g ∕ l); 9/20/65 (v ∕ v ∕ v) adjusted to pH 7.4 with acetic acid, (D) CGE: sodium deoxycholate gel (0.6 M tris-borate buffer (pH 8.1)/ 0.005 M EDTA/ 10% dextran (w ∕ v)/ 0.2% sodium deoxycholate (w ∕ v)/ 10% glycerol (v ∕ v). (E) Evolution of the percentage of dimers in nSEC and CGE in function of the incubation time. The results are the means of three injections. The error bars represent the standard deviations.
Table 1. Percentages of dimers (*) and polymeric insulin complexes (**) as a function of the incubation time using CGE, nSEC and aSEC.































3.4. Application to the analysis of an insulin formulation
The three methods described above (aSEC, nSEC and CGE) were applied to examine an insulin formulation. In the formulations, meta​cresol and glycerol are usually added to induce the formation of hex​amers. This conformation is more stable than monomers, protecting the formulation from aggregation that could happen during storage [29]. The selected formulation (Humuline Regular) contains 100 UI∕ml of human insulin. It was analyzed under four conditions: in its original form, after the addition of an acid, after agitation and after agitation of the acidified formulation.
As can be seen in Fig. 4, the percentages of dimers (*) under the four conditions in CGE and nSEC were similar. The percentage of dimers observed when insulin was agitated was slightly higher than that ob​tained when insulin was acidified. When insulin was acidified and agitated, a higher percentage of dimers was observed with both tech​niques.
The figure also shows results for aSEC: small changes in the per​centage of the dimers were observed (*) under the four conditions (0.18% for the formulation its original form, 0.14% after addition of acid, 0.22% after agitation and 0.31% after agitation of the acidified formulation). 1.6% of polymeric insulin complexes (**) were detected when the formulation was acidified and agitated.
These results are thus in good concordance with those obtained for human insulin as raw material.


Fig. 4. Analysis of an insulin formulation. The percentages of dimers (*) and insulin polymeric complexes (**) are given. The results are the means of two injections. The error bars represent the standard deviations. (A)Insulin for​mulation. (B)Insulin formulation after addition of an acid (4 μL of 6 M HCl for 1 ml of Humuline). (C)Insulin formulation after agitation (24 h at 700 rpm at 37°C). (D)Insulin formulation after addition of an acid (4 μL of 6 M HCl for 1 ml of Humuline) and agitation (24 h at 700 rpm at 37°C). CGE: sodium deox​ycholate gel (0.6 M tris-borate buffer (pH 8.1)/ 0.005 M EDTA/ 10% dextran (w ∕ v)/ 0.2% sodium deoxycholate (w ∕ v)/ 10% glycerol (v ∕ v)), nSEC: 0.1 M sodium phosphate buffer (pH 7.4)∕acetonitrile R/arginine R (1.0 g ∕ l); 9/20/65 (v ∕ v ∕ v) adjusted to pH 7.4 with acetic acid), aSEC: glacial acetic acid R ∕ acet- onitrile R/arginine R (1.0 g ∕ l); 9/20/65 (v ∕ v ∕ v)).
3.5. Stability of human insulin at 4 °C, -20 °C and at room temperature
The CGE method was then used to assess the stability of human insulin as raw material. Insulin samples in acidic and neutral media were stored at room temperature, at 4 °C or at - 20 °C and analyzed by CGE after 1, 5 and 15 days.


As can be seen in Fig. 5, the percentage of dimers increased from 1% to 18% when the insulin solution in acidic medium was stored at room temperature for 15 days. When the samples were stored at 4 °C or at - 20 °C, a very limited tendency to aggregation was observed, even if at day 15 a slightly lower aggregate content was noticed in the sample stored at - 20 °C compared to that at 4°C.
When insulin was prepared in neutral medium and stored for 15 days at room temperature, a slight increase of the percentage of ag​gregates from 0.5% to 2% could be observed. For samples stored at 4 °C or at - 20 °C, almost no aggregation occurred, except at day 15 In this case again a slightly lower aggregate content was obtained for the sample stored at - 20 °C compared to that at 4 °C.
4. Conclusion




Fig. 5. Analysis of an insulin formulation. Percentage of dimers of human in​sulin (4 mg ∕ ml) in acidic and neutral media after 1, 5 and 15 days of storage at room temperature, in the fridge (4 °C) and in the freezer (-20 °C). Samples were analyzed by CGE (0.6 M tris-borate buffer pH 8.1/ 0.005 M EDTA/10% Dextran (w ∕ v)/ 0.2% sodium deoxycholate (w ∕ v)/ 10% Glycerol (v ∕ v)). Results are the mean of two to three replicates. Error bars represent the standard deviations.
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